Functional tricuspid regurgitation of degenerative mitral valve disease: A crucial determinant of survival Aug. 15, 2022 Overview Show transcript Overview Juan A. Crestanello, M.D., is a cardiovascular surgeon and department chair of Cardiovascular Surgery at Mayo Clinic in Rochester, Minnesota. Dr. Crestanello, who specializes in surgery for valvular heart disease, discusses functional tricuspid regurgitation of degenerative mitral valve disease. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentVideoConcomitant tricuspid repair in patients with degenerative mitral regurgitationVideoIncidence and burden of tricuspid regurgitation in patients with atrial fibrillationArticleTricuspid regurgitation impact on outcomes (TRIO): A simple clinical risk score VID-20544142 Medical Professionals Functional tricuspid regurgitation of degenerative mitral valve disease: A crucial determinant of survival